A partnership that benefits patients
What is a clinical trial and how to participate.
Look at our future science
Review our clinical pipeline
What is a clinical trial and how to participate
We have teamed up with the International Red Cross and Red Crescent Movement to solve the challenge of delivering care to vulnerable populations displaced by conflict.
Click through to find the answers to some of our more frequently asked questions on sustainability and responsible business practices.
We are driven by science, innovation and research and strive to share our knowledge with the global community.
Embark and Novo Nordisk enter collaboration to discover novel therapeutics for o ... Read more
Novo Nordisk's operating profit decreased by 6% in Danish kroner and increased b ... Read more
Novo Nordisk expands its biopharm business with the acquisition of the US and Ca ... Read more
Oral semaglutide demonstrates statistically significant reductions in HbA1c and ... Read more
Novo Nordisk A/S - Share repurchase programme ... Read more
Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more
Novo Nordisk A/S purchases B shares worth DKK 1,262 million from Novo Holdings A ... Read more
Danske Bank Winter Seminar, Copenhagen
Citi Global Healthcare Conference, New York
Societe Generale European ESG/SRI Conference, Paris
Financial statement for the first nine months of 2018,
Take an advanced view of the Novo Nordisk share
Click here to find further information
Link to conference call and presentation
Read about Novo Nordisk – A focused healthcare company
See relevant content for private investors
Download relevant Investor Relations material
Peter Hugreffe AnkersenHead of Investor Relations
Anders Mikkelsen Investor Relations Manager
Valdemar Borum Svarrer Investor Relations Manager
Kristoffer Due Berg Investor Relations Manager
Chilie Thomsen Investor Relations Coordinator
Sign up to receive company announcements.
Link to webcast and presentation
